Dynavax

is a California-based biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer...
Read more
Dynavax CEO: Ryan Spencer

CEO

Ryan Spencer

CEO Approval Rating

89/100

Annual Revenue
$330.5M
Employees
350
Funding
$563.3M
Acquisitions
2

Dynavax Competitors

1Seqirus
2Agenus
3Emergent
4Aduro Biotech
5Idera
6Checkmate Pharmaceuticals
7Inovio
8VaxInnate
9Vertex Pharmaceuticals
1022nd Century

Trending Companies